North America Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “North America Biopsy Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Biopsy Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices, Biopsy Forceps and Biopsy Punches

The North America Biopsy Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Biopsy Devices Market.
• Global corporate-level profiles of key companies operating within the North America Biopsy Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Biopsy Devices is segmented as follows –

• Biopsy Guns

• Biopsy Needles

• Vacuum-Assisted Needle Devices

• Biopsy Forceps

• Biopsy Punches

Reasons to Buy

The North America Biopsy Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Acuderm Inc
Argon Medical Devices Inc
Becton Dickinson and Co
Boston Scientific Corp
Coloplast A/S
ConMed Corp
Devicor Medical Products Inc
Henry Schein Inc
Hologic Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 7

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Biopsy Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Biopsy Devices Market, North America 12

3.1 Biopsy Devices Market, North America, Revenue ($m), 2018-2033 12

3.2 Biopsy Devices Market, North America, Revenue ($m), 2018-2033 14

3.3 Biopsy Devices Market, North America, Volume (Units), 2018-2033 16

3.4 Biopsy Devices Market, North America, Volume (Units), 2018-2033 18

3.5 Biopsy Devices Market, North America, Company Share by Revenue ($m), 2024 21

4 Biopsy Devices Market, Canada 23

4.1 Biopsy Devices Market, Canada, Revenue ($m), 2018-2033 23

4.1.1 Biopsy Forceps Market, Canada, Revenue ($m), by Segment, 2018-2033 25

4.1.2 Biopsy Guns Market, Canada, Revenue ($m), by Segment, 2018-2033 27

4.1.3 Biopsy Needles Market, Canada, Revenue ($m), by Segment, 2018-2033 29

4.1.4 Biopsy Punches Market, Canada, Revenue ($m), by Segment, 2018-2033 31

4.1.5 Vacuum-Assisted Needle Devices Market, Canada, Revenue ($m), by Segment, 2018-2033 33

4.2 Biopsy Devices Market, Canada, Volume (Units), 2018-2033 35

4.2.1 Biopsy Forceps Market, Canada, Volume (Units), by Segment, 2018-2033 37

4.2.2 Biopsy Guns Market, Canada, Volume (Units), by Segment, 2018-2033 39

4.2.3 Biopsy Needles Market, Canada, Volume (Units), by Segment, 2018-2033 41

4.2.4 Biopsy Punches Market, Canada, Volume (Units), by Segment, 2018-2033 43

4.2.5 Vacuum-Assisted Needle Devices Market, Canada, Volume (Units), by Segment, 2018-2033 45

4.3 Biopsy Devices Market, Canada, Average Price ($) , 2018-2033 47

4.4 Biopsy Devices Market, Canada, Company Share by Revenue ($m), 2024 49

5 Biopsy Devices Market, Mexico 51

5.1 Biopsy Devices Market, Mexico, Revenue ($m), 2018-2033 51

5.1.1 Biopsy Forceps Market, Mexico, Revenue ($m), by Segment, 2018-2033 53

5.1.2 Biopsy Guns Market, Mexico, Revenue ($m), by Segment, 2018-2033 55

5.1.3 Biopsy Needles Market, Mexico, Revenue ($m), by Segment, 2018-2033 57

5.1.4 Biopsy Punches Market, Mexico, Revenue ($m), by Segment, 2018-2033 59

5.1.5 Vacuum-Assisted Needle Devices Market, Mexico, Revenue ($m), by Segment, 2018-2033 61

5.2 Biopsy Devices Market, Mexico, Volume (Units), 2018-2033 63

5.2.1 Biopsy Forceps Market, Mexico, Volume (Units), by Segment, 2018-2033 65

5.2.2 Biopsy Guns Market, Mexico, Volume (Units), by Segment, 2018-2033 67

5.2.3 Biopsy Needles Market, Mexico, Volume (Units), by Segment, 2018-2033 69

5.2.4 Biopsy Punches Market, Mexico, Volume (Units), by Segment, 2018-2033 71

5.2.5 Vacuum-Assisted Needle Devices Market, Mexico, Volume (Units), by Segment, 2018-2033 73

5.3 Biopsy Devices Market, Mexico, Average Price ($) , 2018-2033 75

5.4 Biopsy Devices Market, Mexico, Company Share by Revenue ($m), 2024 77

6 Biopsy Devices Market, United States 79

6.1 Biopsy Devices Market, United States, Revenue ($m), 2018-2033 79

6.1.1 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2018-2033 81

6.1.2 Biopsy Guns Market, United States, Revenue ($m), by Segment, 2018-2033 83

6.1.3 Biopsy Needles Market, United States, Revenue ($m), by Segment, 2018-2033 85

6.1.4 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2018-2033 87

6.1.5 Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), by Segment, 2018-2033 89

6.2 Biopsy Devices Market, United States, Volume (Units), 2018-2033 91

6.2.1 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2018-2033 94

6.2.2 Biopsy Guns Market, United States, Volume (Units), by Segment, 2018-2033 96

6.2.3 Biopsy Needles Market, United States, Volume (Units), by Segment, 2018-2033 98

6.2.4 Biopsy Punches Market, United States, Volume (Units), by Segment, 2018-2033 101

6.2.5 Vacuum-Assisted Needle Devices Market, United States, Volume (Units), by Segment, 2018-2033 103

6.3 Biopsy Devices Market, United States, Average Price ($) , 2018-2033 105

6.4 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024 107

7 Overview of Key Companies in North America Biopsy Devices Market 109

7.1 Becton Dickinson and Co 109

7.1.1 Company Overview 109

7.2 Hologic Inc 109

7.2.1 Company Overview 109

7.3 Boston Scientific Corp 109

7.3.1 Company Overview 109

7.4 Argon Medical Devices Inc 109

7.4.1 Company Overview 109

7.5 Merit Medical Systems Inc 110

7.5.1 Company Overview 110

7.6 Olympus Corp 110

7.6.1 Company Overview 110

7.7 Devicor Medical Products Inc 110

7.7.1 Company Overview 110

7.8 Medtronic Plc 110

7.8.1 Company Overview 110

8 Biopsy Devices Market Pipeline Products 111

9 Recent Developments 115

9.1 Corporate Communications 115

9.1.1 Feb 18, 2025: Industry Leaders Join Mizzou Cybersecurity Advisory Board 115

9.1.2 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 115

9.2 Financial Announcements 115

9.2.1 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 115

9.2.2 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 117

9.2.3 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 118

9.2.4 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30 118

9.2.5 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results 118

9.2.6 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 119

9.2.7 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 120

9.2.8 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 120

9.2.9 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results 121

9.2.10 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results 121

9.2.11 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance 121

9.2.12 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 122

9.2.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024 123

9.3 Government and Public Interest 124

9.3.1 Jan 14, 2025: NFCR-Supported Scientists Advance Liquid Biopsy Technology 124

9.3.2 Jan 06, 2025: FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials 124

9.3.3 Sep 30, 2024: Study Advocates for Alternative Biopsy Approach to Detecting Prostate Cancer 125

9.3.4 Jul 09, 2024: BioCryst : ORLADEYO (Berotralstat) Approved in Peru 125

9.4 Other Significant Developments 126

9.4.1 Jan 27, 2025: UC Davis Health places order for BiBBInstruments' EndoDrill GI cancer care device 126

9.4.2 Aug 15, 2024: Alpenglow Biosciences And Partners Secure A Total Of $24m For Development Of Alpenglow’s 3d Spatial Pathology Platform 127

9.5 Product News 128

9.5.1 Jun 17, 2025: Clarity Enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx 128

9.5.2 Nov 13, 2024: Fifteen Radiology Partners Physicians Participating in Multiple RSNA 2024 Sessions 129

9.5.3 Nov 11, 2024: Syndeo Medical Announces European MDR Approval for Two Product Brands 131

9.5.4 Sep 19, 2024: Northwestern Medicine Study Advocates for Alternative Biopsy Approach for Detecting Prostate Cancer 132

9.5.5 Sep 13, 2024: Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 132

9.6 Strategy And Business Planning 133

9.6.1 Jun 04, 2025: Wolters Kluwer Launches AI-enhanced UpToDate Enterprise Edition in EMEA 133

9.6.2 Mar 18, 2025: Aiosyn and Pramana partner for real time kidney biopsy assessment 134

10 Appendix 136

10.1 Research Methodology 137

10.1.1 Coverage 137

10.1.2 Secondary Research 137

10.1.3 Primary Research 138

10.1.4 Market Modeling and Forecasting 139

10.1.5 Company Share Analysis 140

10.1.6 Benchmarking 141

10.2 GlobalData Consulting 141

10.3 Contact Us 141

10.4 Disclaimer 142

 

Table

Table 1: Biopsy Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 13

Table 2: Biopsy Devices Market, North America, Revenue ($m), USD Constant, 2018-2033 15

Table 3: Biopsy Devices Market, North America, Volume (Units), 2018-2033 17

Table 4: Biopsy Devices Market, North America, Volume (Units), 2018-2033 19

Table 5: Biopsy Devices Market, North America, Company Share by Revenue ($m), 2024 22

Table 6: Biopsy Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 24

Table 7: Biopsy Forceps Market, Canada, Revenue ($m), USD Constant, 2018-2033 26

Table 8: Biopsy Guns Market, Canada, Revenue ($m), USD Constant, 2018-2033 28

Table 9: Biopsy Needles Market, Canada, Revenue ($m), USD Constant, 2018-2033 30

Table 10: Biopsy Punches Market, Canada, Revenue ($m), USD Constant, 2018-2033 32

Table 11: Vacuum-Assisted Needle Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 34

Table 12: Biopsy Devices Market, Canada, Volume (Units), 2018-2033 36

Table 13: Biopsy Forceps Market, Canada, Volume (Units), 2018-2033 38

Table 14: Biopsy Guns Market, Canada, Volume (Units), 2018-2033 40

Table 15: Biopsy Needles Market, Canada, Volume (Units), 2018-2033 42

Table 16: Biopsy Punches Market, Canada, Volume (Units), 2018-2033 44

Table 17: Vacuum-Assisted Needle Devices Market, Canada, Volume (Units), 2018-2033 46

Table 18: Biopsy Devices Market, Canada, Average Price ($), 2018-2033 47

Table 19: Biopsy Devices Market, Canada, Company Share by Revenue ($m), 2024 50

Table 20: Biopsy Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033 52

Table 21: Biopsy Forceps Market, Mexico, Revenue ($m), USD Constant, 2018-2033 54

Table 22: Biopsy Guns Market, Mexico, Revenue ($m), USD Constant, 2018-2033 56

Table 23: Biopsy Needles Market, Mexico, Revenue ($m), USD Constant, 2018-2033 58

Table 24: Biopsy Punches Market, Mexico, Revenue ($m), USD Constant, 2018-2033 60

Table 25: Vacuum-Assisted Needle Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033 62

Table 26: Biopsy Devices Market, Mexico, Volume (Units), 2018-2033 64

Table 27: Biopsy Forceps Market, Mexico, Volume (Units), 2018-2033 66

Table 28: Biopsy Guns Market, Mexico, Volume (Units), 2018-2033 68

Table 29: Biopsy Needles Market, Mexico, Volume (Units), 2018-2033 70

Table 30: Biopsy Punches Market, Mexico, Volume (Units), 2018-2033 72

Table 31: Vacuum-Assisted Needle Devices Market, Mexico, Volume (Units), 2018-2033 74

Table 32: Biopsy Devices Market, Mexico, Average Price ($), 2018-2033 75

Table 33: Biopsy Devices Market, Mexico, Company Share by Revenue ($m), 2024 78

Table 34: Biopsy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 80

Table 35: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, 2018-2033 82

Table 36: Biopsy Guns Market, United States, Revenue ($m), USD Constant, 2018-2033 84

Table 37: Biopsy Needles Market, United States, Revenue ($m), USD Constant, 2018-2033 86

Table 38: Biopsy Punches Market, United States, Revenue ($m), USD Constant, 2018-2033 88

Table 39: Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 90

Table 40: Biopsy Devices Market, United States, Volume (Units), 2018-2033 92

Table 41: Biopsy Forceps Market, United States, Volume (Units), 2018-2033 95

Table 42: Biopsy Guns Market, United States, Volume (Units), 2018-2033 97

Table 43: Biopsy Needles Market, United States, Volume (Units), 2018-2033 99

Table 44: Biopsy Punches Market, United States, Volume (Units), 2018-2033 102

Table 45: Vacuum-Assisted Needle Devices Market, United States, Volume (Units), 2018-2033 104

Table 46: Biopsy Devices Market, United States, Average Price ($), 2018-2033 105

Table 47: Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024 108

Table 48: Biopsy Devices Market Pipeline Products 111

Table 49: Total Number of Primary Research Participants, General Surgery Devices Market, by Country 138

Figures

Figure 1: Biopsy Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 12

Figure 2: Biopsy Devices Market, North America, Revenue ($m), USD Constant, 2018-2033 14

Figure 3: Biopsy Devices Market, North America, Volume (Units), 2018-2033 16

Figure 4: Biopsy Devices Market, North America, Volume (Units), 2018-2033 18

Figure 5: Biopsy Devices Market, North America, Company Share (%), 2024 21

Figure 6: Biopsy Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 23

Figure 7: Biopsy Forceps Market, Canada, Revenue ($m), USD Constant, 2018-2033 25

Figure 8: Biopsy Guns Market, Canada, Revenue ($m), USD Constant, 2018-2033 27

Figure 9: Biopsy Needles Market, Canada, Revenue ($m), USD Constant, 2018-2033 29

Figure 10: Biopsy Punches Market, Canada, Revenue ($m), USD Constant, 2018-2033 31

Figure 11: Vacuum-Assisted Needle Devices Market, Canada, Revenue ($m), USD Constant, 2018-2033 33

Figure 12: Biopsy Devices Market, Canada, Volume (Units), 2018-2033 35

Figure 13: Biopsy Forceps Market, Canada, Volume (Units), 2018-2033 37

Figure 14: Biopsy Guns Market, Canada, Volume (Units), 2018-2033 39

Figure 15: Biopsy Needles Market, Canada, Volume (Units), 2018-2033 41

Figure 16: Biopsy Punches Market, Canada, Volume (Units), 2018-2033 43

Figure 17: Vacuum-Assisted Needle Devices Market, Canada, Volume (Units), 2018-2033 45

Figure 18: Biopsy Devices Market, Canada, Company Share (%), 2024 49

Figure 19: Biopsy Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033 51

Figure 20: Biopsy Forceps Market, Mexico, Revenue ($m), USD Constant, 2018-2033 53

Figure 21: Biopsy Guns Market, Mexico, Revenue ($m), USD Constant, 2018-2033 55

Figure 22: Biopsy Needles Market, Mexico, Revenue ($m), USD Constant, 2018-2033 57

Figure 23: Biopsy Punches Market, Mexico, Revenue ($m), USD Constant, 2018-2033 59

Figure 24: Vacuum-Assisted Needle Devices Market, Mexico, Revenue ($m), USD Constant, 2018-2033 61

Figure 25: Biopsy Devices Market, Mexico, Volume (Units), 2018-2033 63

Figure 26: Biopsy Forceps Market, Mexico, Volume (Units), 2018-2033 65

Figure 27: Biopsy Guns Market, Mexico, Volume (Units), 2018-2033 67

Figure 28: Biopsy Needles Market, Mexico, Volume (Units), 2018-2033 69

Figure 29: Biopsy Punches Market, Mexico, Volume (Units), 2018-2033 71

Figure 30: Vacuum-Assisted Needle Devices Market, Mexico, Volume (Units), 2018-2033 73

Figure 31: Biopsy Devices Market, Mexico, Company Share (%), 2024 77

Figure 32: Biopsy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 79

Figure 33: Biopsy Forceps Market, United States, Revenue ($m), USD Constant, 2018-2033 81

Figure 34: Biopsy Guns Market, United States, Revenue ($m), USD Constant, 2018-2033 83

Figure 35: Biopsy Needles Market, United States, Revenue ($m), USD Constant, 2018-2033 85

Figure 36: Biopsy Punches Market, United States, Revenue ($m), USD Constant, 2018-2033 87

Figure 37: Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), USD Constant, 2018-2033 89

Figure 38: Biopsy Devices Market, United States, Volume (Units), 2018-2033 91

Figure 39: Biopsy Forceps Market, United States, Volume (Units), 2018-2033 94

Figure 40: Biopsy Guns Market, United States, Volume (Units), 2018-2033 96

Figure 41: Biopsy Needles Market, United States, Volume (Units), 2018-2033 98

Figure 42: Biopsy Punches Market, United States, Volume (Units), 2018-2033 101

Figure 43: Vacuum-Assisted Needle Devices Market, United States, Volume (Units), 2018-2033 103

Figure 44: Biopsy Devices Market, United States, Company Share (%), 2024 107

North America Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others in real time.

  • Access a live North America Biopsy Devices Market Outlook to 2033: Biopsy Guns, Biopsy Needles, Vacuum-Assisted Needle Devices and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.